Given its role in the key pathological processes of Alzheimer’s disease—including cerebral hypoperfusion, neuroinflammation, and impaired synaptic plasticity—HIF-1α emerges as a promising therapeutic target. Here, HIF1A is linked to Alzheimer disease.